Pitcairn’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,648
| Closed | -$212K | – | 746 |
|
|
2024
Q1 | $212K | Sell |
5,648
-1,259
| -18% | -$47.3K | 0.01% | 676 |
|
|
2023
Q4 | $387K | Sell |
6,907
-656
| -9% | -$36.7K | 0.03% | 474 |
|
|
2023
Q3 | $312K | Sell |
7,563
-1,318
| -15% | -$54.4K | 0.03% | 492 |
|
|
2023
Q2 | $496K | Buy |
8,881
+1,342
| +18% | +$74.9K | 0.04% | 359 |
|
|
2023
Q1 | $421K | Buy |
7,539
+1,898
| +34% | +$106K | 0.04% | 389 |
|
|
2022
Q4 | $206K | Buy |
+5,641
| New | +$206K | 0.02% | 561 |
|
|
2022
Q3 | – | Sell |
-5,507
| Closed | -$249K | – | 600 |
|
|
2022
Q2 | $249K | Buy |
5,507
+1,653
| +43% | +$74.7K | 0.03% | 495 |
|
|
2022
Q1 | $293K | Buy |
3,854
+2,480
| +180% | +$189K | 0.03% | 501 |
|
|
2021
Q4 | $205K | Buy |
+1,374
| New | +$205K | 0.01% | 613 |
|